PL2169387T3 - Wieloparametryczna, wysokoczuła metoda analizy rzadkich obiektów w próbkach biologicznych - Google Patents

Wieloparametryczna, wysokoczuła metoda analizy rzadkich obiektów w próbkach biologicznych

Info

Publication number
PL2169387T3
PL2169387T3 PL09251888T PL09251888T PL2169387T3 PL 2169387 T3 PL2169387 T3 PL 2169387T3 PL 09251888 T PL09251888 T PL 09251888T PL 09251888 T PL09251888 T PL 09251888T PL 2169387 T3 PL2169387 T3 PL 2169387T3
Authority
PL
Poland
Prior art keywords
multiparameter
biological samples
highly sensitive
sensitive method
analyzing rare
Prior art date
Application number
PL09251888T
Other languages
English (en)
Inventor
Mark Carle Connelly
Frank Coumans
Steven Gross
James Michael Kelly
Original Assignee
Janssen Diagnostics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41611032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2169387(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Diagnostics Llc filed Critical Janssen Diagnostics Llc
Publication of PL2169387T3 publication Critical patent/PL2169387T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6456—Spatial resolved fluorescence measurements; Imaging
    • G01N21/6458—Fluorescence microscopy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G01N2021/6441—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Ecology (AREA)
  • Physiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
PL09251888T 2008-07-29 2009-07-28 Wieloparametryczna, wysokoczuła metoda analizy rzadkich obiektów w próbkach biologicznych PL2169387T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/181,399 US9134237B2 (en) 2005-09-20 2008-07-29 High sensitivity multiparameter method for rare event analysis in a biological sample
EP20090251888 EP2169387B1 (en) 2008-07-29 2009-07-28 A high sensivity multiparameter method for rare event analysis in a biological sample

Publications (1)

Publication Number Publication Date
PL2169387T3 true PL2169387T3 (pl) 2015-09-30

Family

ID=41611032

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09251888T PL2169387T3 (pl) 2008-07-29 2009-07-28 Wieloparametryczna, wysokoczuła metoda analizy rzadkich obiektów w próbkach biologicznych

Country Status (14)

Country Link
US (1) US9134237B2 (pl)
EP (1) EP2169387B1 (pl)
JP (1) JP6109464B2 (pl)
KR (2) KR101764597B1 (pl)
CN (1) CN101672779B (pl)
BR (2) BRPI0902559A2 (pl)
CA (2) CA2674187C (pl)
DK (1) DK2169387T3 (pl)
ES (1) ES2542061T3 (pl)
HU (1) HUE026779T2 (pl)
IL (1) IL199798A (pl)
MX (1) MX2009008060A (pl)
PL (1) PL2169387T3 (pl)
PT (1) PT2169387E (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2623405C (en) 2005-09-20 2014-11-25 Immunivest Corporation Methods and composition to generate unique sequence dna probes labeling of dna probes and the use of these probes
WO2011050103A1 (en) 2009-10-21 2011-04-28 The Scripps Research Institute Method of using non-rare cells to detect rare cells
EP3517630B1 (en) 2010-10-06 2022-01-19 Institució Catalana de Recerca i Estudis Avançats Method for the diagnosis, prognosis and treatment of breast cancer metastasis
US10114020B2 (en) 2010-10-11 2018-10-30 Mbio Diagnostics, Inc. System and device for analyzing a fluidic sample
JP6010034B2 (ja) * 2011-08-30 2016-10-19 オリンパス株式会社 標的粒子の検出方法
WO2013072571A1 (fr) * 2011-11-17 2013-05-23 Institut Gustave Roussy Methode de caracterisation de cellules tumorales circulantes et application au diagnostic
EP2650682A1 (en) 2012-04-09 2013-10-16 Fundació Privada Institut de Recerca Biomèdica Method for the prognosis and treatment of cancer metastasis
EP3467124A1 (en) 2012-06-06 2019-04-10 Fundació Institut de Recerca Biomèdica IRB (Barcelona) Method for the diagnosis, prognosis and treatment of lung cancer metastasis
US10119171B2 (en) 2012-10-12 2018-11-06 Inbiomotion S.L. Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
KR101872965B1 (ko) 2012-10-12 2018-06-29 인바이오모션 에스.엘. Ｃ―ｍａｆ를 이용하는 전립선암 전이의 진단, 예후 및 치료 방법
WO2014070235A1 (en) 2012-10-29 2014-05-08 Mbio Diagnostics, Inc. Biological particle identification system, cartridge and associated methods
US10527624B2 (en) 2014-01-27 2020-01-07 Epic Sciences, Inc. Circulating tumor cell diagnostics for prostate cancer biomarkers
EP3108246B1 (en) 2014-02-21 2019-10-09 Epic Sciences, Inc. Methods for analyzing rare circulating cells
WO2016033103A1 (en) * 2014-08-25 2016-03-03 Creatv Microtech, Inc. Use of circulating cell biomarkers in the blood for detection and diagnosis of diseases and methods of isolating them
KR20170093182A (ko) 2014-12-11 2017-08-14 인바이오모션 에스.엘. 인간 c-maf에 대한 결합 구성원
WO2016115537A2 (en) * 2015-01-15 2016-07-21 Massachusetts Institute Of Technology Systems, methods, and apparatus for in vitro single-cell identification and recovery
GB201507202D0 (en) 2015-04-28 2015-06-10 Stfc Science & Technology Receptor tyosine kinase biomarkers
KR20180100607A (ko) * 2016-01-07 2018-09-11 크리에티브이 마이크로테크, 인크. 순차적인 형광 소광 및 재염색을 이용한 생물학적 시료의 다중-표현형적 서브타이핑
AU2017271385B2 (en) 2016-05-25 2023-10-05 Inbiomotion S.L. Therapeutic treatment of breast cancer based on c-MAF status
US20190234874A1 (en) * 2016-07-19 2019-08-01 Altius Institute For Biomedical Sciences Methods for fluorescence imaging microscopy
MX2020005182A (es) 2017-11-22 2020-08-17 Inbiomotion Sl Tratamiento terapeutico del cancer de mama basado en el estado del c-maf.
CN111330311B (zh) * 2020-02-13 2021-02-23 浙江大学 一种相变诱导靶标富集的方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578444A (en) 1991-06-27 1996-11-26 Genelabs Technologies, Inc. Sequence-directed DNA-binding molecules compositions and methods
AU2636995A (en) * 1994-05-18 1995-12-05 Research And Development Institute, Inc. Simple, rapid method for the detection, identification and enumeration of specific viable microorganisms
JPH10500310A (ja) * 1994-05-19 1998-01-13 ダコ アクティーゼルスカブ 淋菌及びトラコーマ クラミジアの検出のためのｐｎａ プローブ
CN1153064C (zh) 1996-04-05 2004-06-09 约翰斯·霍普金斯大学 富集稀少细胞的方法
DE19709348C2 (de) * 1996-05-29 1999-07-01 Schubert Walter Dr Md Automatisches Multi-Epitop-Ligand-Kartierungsverfahren
GB9716664D0 (en) * 1997-08-06 1997-10-15 Norwegian Inst Of Fisheries & A method of removing nucleic acid contamination reactions
US20020172987A1 (en) * 1998-02-12 2002-11-21 Terstappen Leon W.M.M. Methods and reagents for the rapid and efficient isolation of circulating cancer cells
BR9907852A (pt) * 1998-02-12 2000-10-24 Immunivest Corp Processos para detectar e enumerar células raras e cancerosas em uma população celular mista, para diagnosticar câncer de estágio precoce em um paciente de teste, para determinar a probabilidade de recorrência de câncer em um paciente humano anteriormente tratado de câncer, para distinguir um carcinoma confinado ao órgão de um carcinoma com propriedades metastáticas, para acompanhar a situação de remissão em um paciente humano com câncer que passa pelo tratamento de terapia contra o câncer e para aumentar quantidades de células epiteliais circulantes em uma amostra de sangue, partìcula magnética revestida, composição, conjuntos de teste para avaliar uma amostra de paciente quanto a presença de células raras circulantes, quanto a presença de células de tumor circulantes, quanto a presença de células de câncer de mama circulantes, quanto a presença de células de câncer de próstata circulantes, quanto a presença de células de câncer de cólon circulantes, quanto a presença de células de câncer de bexiga circulantes e para monitorar um paciente quanto a recorrência de câncer, e, fração de sangue periférico enriquecido quanto a células neoplásticas circulantes
AU758466B2 (en) 1998-06-02 2003-03-20 Yale University Multiparametric fluorescence in situ hybridization
US6429293B1 (en) * 1998-06-26 2002-08-06 Hsc Research And Development Limited Partnership Sculpin-type antifreeze polypeptides and nucleic acids
US6960449B2 (en) 1999-02-10 2005-11-01 Cell Works Diagnostics, Inc. Class characterization of circulating cancer cells isolated from body fluids and methods of use
WO2001006014A1 (en) 1999-07-19 2001-01-25 American Laboratory Technologies, Inc. Removing repetitive sequences from dna
US6203992B1 (en) 1999-10-15 2001-03-20 Abbott Laboratories Nucleic acid primers and probes for detecting tumor cells
CA2388528A1 (en) * 1999-11-04 2001-05-10 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
CA2435503C (en) 2001-01-19 2011-02-22 Ludwig Institute For Cancer Research Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
CA2434604C (en) * 2001-02-12 2010-09-28 Immunivest Corporation Cartridge for containing a specimen sample for optical analysis
GB0111324D0 (en) * 2001-05-09 2001-07-04 Unilever Plc Ambient stable beverage
US20030129626A1 (en) 2001-09-24 2003-07-10 Nielsen Kirsten Vang Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid
US20030082632A1 (en) * 2001-10-25 2003-05-01 Cytoprint, Inc. Assay method and apparatus
JP2005507997A (ja) 2001-10-26 2005-03-24 イムニベスト・コーポレイション 同一試料についての包括的核酸および形態学的特徴のマルチパラメーター分析
WO2003048378A2 (en) * 2001-12-04 2003-06-12 Euregen Llc Methods and compositions for selectively cleaving dna containing duplex acids in a complex nucleic acid mixture
MXPA04006154A (es) 2001-12-21 2004-11-01 Immunex Corp Celulas madre endoteliales, poblaciones y metodos para el aislamiento y uso de las mismas.
EP1497447A4 (en) 2002-04-12 2006-09-20 Univ Missouri US ECIST MICROARRAYSES FOR DUAL SCREENING OF DNA HYPERMETHYLATION AND GENE INACTIVATION, AND FOR USE IN AN INTEGRATED SYSTEM FOR EVALUATING GENE EXPRESSION, DNA METHYLATION AND ACETYLATION OF HISTONE
JP2005524833A (ja) 2002-05-03 2005-08-18 イムニベスト・コーポレイション 分析細胞イメージング用のデバイスおよび方法
US7648678B2 (en) 2002-12-20 2010-01-19 Dako Denmark A/S Method and system for pretreatment of tissue slides
CA2516795C (en) 2003-02-27 2013-01-15 Immunivest Corporation Circulating tumor cells (ctc's): early assessment of time to progression,_survival and response to therapy in metastatic cancer patients
EP1604040B1 (en) * 2003-03-07 2010-10-13 Rubicon Genomics, Inc. Amplification and analysis of whole genome and whole transcriptome libraries generated by a dna polymerization process
WO2004083386A2 (en) 2003-03-13 2004-09-30 A.L. Tech Biomedical, Inc. Methods of making repetitive sequences removed probes and use thereof
EP1626732B1 (en) * 2003-05-22 2013-04-03 CHIESI FARMACEUTICI S.p.A. Means for preventing and treating cellular death and their biological applications
CA2539108A1 (en) 2003-09-18 2005-03-31 Immunivest Corporation Operator independent programmable sample preparation and analysis system
DE102005006237A1 (de) * 2005-02-10 2006-08-24 Henkel Kgaa Verfahren zur Bestimmung von Keimen
EP1722230A3 (en) 2005-04-27 2009-05-27 MPB MelTec Patent- und Beteiligungsgesellschaft mbH Method for detection of a disease-specific combinatorial molecular pattern motif in a tissue sample of a patient's skin
CA2623405C (en) 2005-09-20 2014-11-25 Immunivest Corporation Methods and composition to generate unique sequence dna probes labeling of dna probes and the use of these probes
US7659978B2 (en) * 2006-10-19 2010-02-09 Chemimage Corporation Photobleaching by high power pulses

Also Published As

Publication number Publication date
US9134237B2 (en) 2015-09-15
US20090029378A1 (en) 2009-01-29
DK2169387T3 (en) 2015-05-26
HK1140820A1 (en) 2010-10-22
CA2674187C (en) 2017-09-12
KR20100012847A (ko) 2010-02-08
BR122018015761B1 (pt) 2019-10-22
ES2542061T3 (es) 2015-07-30
EP2169387B1 (en) 2015-04-22
HUE026779T2 (en) 2016-07-28
BR122018015761B8 (pt) 2021-07-27
KR20170094523A (ko) 2017-08-18
CN101672779B (zh) 2016-01-06
EP2169387A3 (en) 2011-03-09
CA2975186A1 (en) 2010-01-29
JP2010029187A (ja) 2010-02-12
JP6109464B2 (ja) 2017-04-05
IL199798A (en) 2014-08-31
BRPI0902559A2 (pt) 2011-04-05
MX2009008060A (es) 2010-07-01
IL199798A0 (en) 2010-05-17
CA2674187A1 (en) 2010-01-29
KR101764597B1 (ko) 2017-08-03
EP2169387A2 (en) 2010-03-31
CN101672779A (zh) 2010-03-17
PT2169387E (pt) 2015-06-03

Similar Documents

Publication Publication Date Title
PL2169387T3 (pl) Wieloparametryczna, wysokoczuła metoda analizy rzadkich obiektów w próbkach biologicznych
DK3101141T3 (da) Fremgangsmåde til methyleringsanalyse
DK2084519T3 (da) Røntgenfluorescens-analysefremgangsmåde
IL230076A0 (en) Certain chemical entities, compositions and methods
EP2144057A4 (en) CHIP OF ANALYSIS AND APPARATUS OF ANALYSIS
DK2371958T3 (da) HIDTIL UKENDTE siRNA OG FREMGANGSMÅDER TIL ANVENDELSE DERAF
BRPI0907766A2 (pt) Método e sistema para análise de dados de espectro
IL196530A0 (en) Analyte testing method and system
IL200352A0 (en) Analyte testing method and system
BRPI0715346A2 (pt) Detecção de analitos e ácidos nucléicos
EP2312291A4 (en) ANALYSIS PROCEDURE AND ANALYSIS SYSTEM
BRPI0820159A2 (pt) Aparelho e método de processamento de dados.
EP2454587A4 (en) DEVICES, METHODS, AND KITS FOR DETERMINING ANALYZ CONCENTRATIONS
EP2557158A4 (en) BIOPOLYMER ANALYSIS PROCEDURE, BIOPOLYMER ANALYZER AND BIOPOLYMER ANALYSIS CHIP
FI20075897L (fi) Menetelmä ja järjestely tiedonhakutulosten käsittelemiseksi
BRPI0819643A2 (pt) Aparelho e método de processamento de dados
BRPI0819645A2 (pt) Aparelho e método de processamento de dados
BRPI0910510A2 (pt) método de análise de freqüência de dados e programa de computador
BRPI0918357A2 (pt) sistema e método para processamento de amostras
BRPI0919717A2 (pt) aparelho e método de processamento de informação, e , programa
DK2107373T3 (da) Analysechip og analysefremgangsmåde
BRPI0820168A2 (pt) Aparelho e método de processamento de dados
JP2010048806A5 (ja) 流体内検体濃度検知システム
BRPI1006379A2 (pt) método e analisador de dados
EP2274098A4 (en) DEVICES FOR PREPARING MULTICAPILLAR SAMPLES AND METHODS FOR TREATING ANALYTES